Telomerase activity in ductal carcinoma in situ of the breast
โ Scribed by B. Shpitz; S. Zimlichman; R. Zemer; Y. Bomstein; T. Zehavi; S. Liverant; J. Bernehim; Z. Kaufman; E. Klein; Y. Shapira; A.pitz Klein
- Book ID
- 110234942
- Publisher
- Springer US
- Year
- 1999
- Tongue
- English
- Weight
- 47 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr
Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents